Fibroblast Growth Factor 21 Ameliorates Na(V)1.5 and Kir2.1 Channel Dysregulation in Human AC16 Cardiomyocytes.

Li J, Li Y, Liu Y, Yu H, Xu N, Huang D, Xue Y, Li S, Chen H, Liu J, Li Q, Zhao Y, Zhang R, Xue H, Sun Y, Li M, Li P, Liu M, Zhang Z, Li X, Du W, Wang N, Yang B

Open source

DOI: 10.3389/fphar.2021.715466
Published: 2021
Container: Frontiers in pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2021.715466,
  title = {Fibroblast Growth Factor 21 Ameliorates Na(V)1.5 and Kir2.1 Channel Dysregulation in Human AC16 Cardiomyocytes.},
  author = {Li J and Li Y and Liu Y and Yu H and Xu N and Huang D and Xue Y and Li S and Chen H and Liu J and Li Q and Zhao Y and Zhang R and Xue H and Sun Y and Li M and Li P and Liu M and Zhang Z and Li X and Du W and Wang N and Yang B},
  year = {2021},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2021.715466},
  url = {https://doi.org/10.3389/fphar.2021.715466}
}

RIS

TY  - JOUR
TI  - Fibroblast Growth Factor 21 Ameliorates Na(V)1.5 and Kir2.1 Channel Dysregulation in Human AC16 Cardiomyocytes.
AU  - Li J
AU  - Li Y
AU  - Liu Y
AU  - Yu H
AU  - Xu N
AU  - Huang D
AU  - Xue Y
AU  - Li S
AU  - Chen H
AU  - Liu J
AU  - Li Q
AU  - Zhao Y
AU  - Zhang R
AU  - Xue H
AU  - Sun Y
AU  - Li M
AU  - Li P
AU  - Liu M
AU  - Zhang Z
AU  - Li X
AU  - Du W
AU  - Wang N
AU  - Yang B
PY  - 2021
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2021.715466
UR  - https://doi.org/10.3389/fphar.2021.715466
ER  -

APA

J, L., Y, L., Y, L., H, Y., N, X., D, H., Y, X., S, L., H, C., J, L., Q, L., Y, Z., R, Z., H, X., Y, S., M, L., P, L., M, L., Z, Z., X, L., W, D., N, W., & B, Y. (2021). Fibroblast Growth Factor 21 Ameliorates Na(V)1.5 and Kir2.1 Channel Dysregulation in Human AC16 Cardiomyocytes.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2021.715466

Source records

pubmed · retrieved 2026-09-25T04:10:26.466Z